combinatori
human
immunoglobulin
gene
librari
construct
peripher
lymphocyt
two
patient
recov
sever
acut
respiratori
syndrom
sar
librari
screen
product
fab
antibodi
fragment
recombin
spike
protein
sarsassoci
coronaviru
sarscov
one
fab
clone
react
spike
protein
enzymelink
immunosorb
assay
dissoci
constant
immunofluoresc
microscopi
reveal
react
sarscovinfect
cell
librari
seem
potent
tool
product
human
antibodi
sarscov
fig
deduc
amino
acid
sequenc
gene
code
heavi
h
light
l
chain
variabl
region
human
monoclon
antibodi
fab
specif
spike
protein
sarscov
note
clin
vaccin
immunol
sever
acut
respiratori
syndrom
sar
lifethreaten
form
atyp
pneumonia
caus
newli
identifi
viru
sarsassoci
coronaviru
sarscov
diseas
emerg
southern
china
late
spread
worldwid
total
case
sar
identifi
countri
end
patient
die
fatal
rate
world
health
organ
http
www
whointcsrsarscountryt
despit
medic
import
diseas
effect
vaccin
therapi
yet
avail
howev
neutral
antibodi
sarscov
broadli
elicit
sar
patient
also
report
transfer
mous
immun
serum
passiv
immun
reduc
pulmonari
viral
titer
significantli
infect
mice
sarscov
member
famili
coronavirida
spike
glycoprotein
highli
antigen
envelop
protein
respons
receptor
bind
membran
fusion
therefor
human
monoclon
antibodi
spike
protein
may
potenti
passiv
immun
reagent
use
reduc
rate
mortal
sarscov
infect
report
gener
human
monoclon
antibodi
fab
fragment
sarscov
spike
protein
combinatori
immunoglobulin
gene
librari
deriv
two
patient
recov
sar
five
millilit
peripher
blood
obtain
two
patient
recov
sar
shanghai
hospit
infecti
diseas
serum
sampl
posit
sarscov
enzymelink
immunosorb
assay
elisa
titer
greater
construct
immunoglobulin
gene
librari
peripher
lymphocyt
perform
describ
previous
briefli
total
rna
purifi
lymphocyt
subject
revers
transcriptionpcr
gene
code
light
chain
fd
region
heavi
chain
amplifi
cycl
pcr
lightchain
gene
first
ligat
express
vector
introduc
escherichia
coli
cell
vector
insert
ligat
fd
heavychain
gene
introduc
e
coli
cell
prepar
recombin
spike
protein
sarscov
gene
code
protein
posit
isol
first
synthes
use
overlap
oligonucleotid
primer
partial
gene
correspond
residu
amplifi
pcr
primer
amplifi
gene
ligat
vector
introduc
e
coli
recombin
protein
obtain
inclus
bodi
refold
first
screen
posit
clone
produc
antisarscov
antibodi
perform
essenti
describ
previous
briefli
approxim
e
coli
coloni
per
plate
grown
luria
broth
agar
contain
gml
ampicillin
bacteri
coloni
first
transfer
nitrocellulos
filter
filter
replac
surfac
fresh
plate
contain
mm
iptg
ampicillin
incub
h
filter
treat
chloroform
vapor
lysi
buffer
contain
mm
trishcl
ph
mm
nacl
mm
mgcl
bovin
serum
albumin
g
dnase
per
ml
g
lysozym
per
ml
overnight
filter
wash
phosphatebuff
salin
pb
contain
tween
pbst
filter
block
pbst
contain
skim
milk
filter
incub
g
recombin
spike
protein
sarscov
sera
patient
donor
lymphocyt
posit
signal
filter
detect
horseradish
peroxidas
hrp
conjug
goat
antibodi
human
immunoglobulin
g
igg
fc
icn
pharmaceut
aurora
oh
immunostain
kit
konica
co
tokyo
japan
posit
clone
identifi
origin
plate
cultur
ml
super
broth
g
trypton
g
yeast
extract
g
acid
per
liter
ph
contain
ampicillin
optic
densiti
od
nm
final
concentr
ad
bacteri
cultur
incub
overnight
h
bacteria
pellet
centrifug
resuspend
ml
pb
contain
mm
phenylmethylsulfonyl
fluorid
sonic
lysat
centrifug
g
min
supernat
subject
second
screen
elisa
well
elisa
plate
treat
recombin
partial
spike
protein
gwell
dilut
mm
sodium
bicarbon
buffer
plate
wash
pbst
treat
pb
contain
skim
milk
h
one
hundr
microlit
supernat
ad
well
plate
incub
h
room
temperatur
plate
wash
well
incub
l
hrpconjug
goat
antibodi
human
igg
fab
icn
pharmaceut
h
room
temperatur
treat
l
substrat
ophenylenediamin
citric
acidphosph
buffer
ph
includ
hydrogen
peroxid
reaction
stop
addit
l
n
h
min
optic
densiti
nm
determin
cutoff
point
posit
result
defin
od
valu
standard
deviat
mean
healthi
control
serum
sampl
dilut
posit
clone
cultur
liter
super
broth
medium
ml
result
supernat
prepar
sonic
describ
purif
fab
perform
use
hisbind
resin
novagen
madison
wi
accord
manufactur
instruct
reactiv
purifi
fab
recombin
spike
protein
sarscov
examin
western
immunoblot
analysi
recombin
spike
protein
electrophores
reduc
condit
acrylamid
gel
contain
sodium
dodecyl
sulfat
transfer
polyvinyliden
difluorid
membran
spike
protein
blot
purif
fab
follow
hrpconjug
goat
antibodi
human
igg
fab
konica
immunostain
kit
elisa
western
immunoblot
assay
patient
sera
polyclon
rabbit
antibodi
spike
protein
imgenex
san
diego
ca
use
posit
control
normal
human
fab
oem
concept
tom
river
nj
normal
human
serum
normal
rabbit
igg
use
neg
control
sarscovinfect
vero
cell
purchas
euroimmun
us
llc
boonton
township
nj
use
indirect
immunofluoresc
assay
cell
block
pb
contain
skim
milk
cell
incub
gml
fab
normal
human
fab
min
fluorescein
isothiocyanatelabel
goat
antibodi
human
igg
fab
icn
pharmaceut
use
secondari
antibodi
affin
constant
fab
assess
determin
surfac
plasmon
reson
biacor
instrument
biacor
ab
uppsala
sweden
recombin
spike
protein
immobil
onto
chip
biacor
associ
dissoci
constant
determin
use
biaevalu
clone
combinatori
immunoglobulin
gene
librari
screen
product
antisarscov
human
fab
incub
recombin
sarscov
spike
protein
follow
incub
patient
sera
antihuman
igg
fc
secondari
antibodi
three
clone
show
posit
signal
second
screen
three
fab
clone
elisa
one
clone
design
react
specif
recombin
spike
protein
western
blot
analysi
react
protein
patient
sera
commerci
rabbit
polyclon
antibodi
sarscov
spike
protein
data
shown
test
abil
bind
nativ
sarscov
infect
cell
indirect
immunofluoresc
assay
result
show
specif
recogn
infect
cell
noninfect
cell
fig
affin
recombin
protein
analyz
surfac
plasmon
reson
assay
associ
dissoci
constant
respect
heavyand
lightchain
gene
sequenc
deduc
amino
acid
variabl
region
shown
fig
nucleotid
sequenc
analyz
igblast
program
heavychain
gene
nearest
germ
line
v
segment
homolog
closest
dsegment
germ
line
closest
jsegment
germ
line
sever
method
prepar
human
monoclon
antibodi
recent
develop
one
effect
method
phage
display
system
inde
report
recombin
neutral
human
antibodi
sarscov
spike
protein
could
gener
larg
human
antibodi
phage
display
librari
contrast
present
studi
recombin
human
monoclon
antibodi
fab
fragment
sarscov
spike
protein
could
gener
consider
smaller
librari
deriv
patient
recov
sar
moreov
screen
librari
antibodi
express
fab
fragment
e
coli
bacteri
coloni
examin
directli
without
use
phage
display
system
sar
patient
report
antisarscov
antibodi
becom
detect
day
infect
correl
declin
viral
load
also
demonstr
serum
sampl
obtain
sar
patient
contain
neutral
antibodi
sarscov
neutral
activ
could
attribut
igg
high
igg
titer
sarscov
shown
elisa
also
confirm
two
patient
studi
recent
gener
neutral
human
monoclon
antibodi
surfac
lectin
protozoan
parasit
entamoeba
histolytica
use
combinatori
immunoglobulin
gene
librari
prepar
symptomat
patient
asymptomat
cyst
passer
although
antibodi
titer
cyst
passer
lower
symptomat
patient
proport
antibodi
recogn
surfac
antigen
seem
higher
asymptomat
individu
use
lymphocyt
patient
recov
symptomat
condit
would
use
way
obtain
neutral
antibodi
effici
use
memori
b
cell
patient
recov
sar
product
human
monoclon
antibodi
sarscov
also
demonstr
method
immort
b
cell
epsteinbarr
viru
demonstr
natur
receptor
sarscov
angiotensinconvert
enzym
bind
site
receptor
residu
spike
protein
although
neutral
activ
toward
sarscov
yet
evalu
recombin
spike
protein
use
screen
present
studi
residu
includ
receptorbind
site
recent
report
one
neutral
human
singlechain
variableregion
fragment
bind
similar
part
residu
spike
protein
dissoci
constant
therefor
affin
spike
protein
demonstr
studi
seem
higher
singlechain
variableregion
fragment
conclus
use
immunoglobulin
gene
librari
prepar
patient
recov
sar
would
potent
strategi
product
human
antibodi
sarscov
nucleotid
sequenc
access
number
nucleotid
sequenc
data
report
paper
deposit
ddbj
embl
genbank
databas
access
number
